News

Icosavax Soars as AstraZeneca Announces Acquisition Deal

1 Mins read

Icosavax, a Seattle-based vaccine developer, experienced a significant boost in stock prices, surging by 47% in premarket trading on Tuesday. The reason for this surge is the recent announcement of a deal between Icosavax and pharmaceutical giant AstraZeneca.

AstraZeneca’s shares also saw an increase of 1.8% in premarket trading following news of the acquisition. The deal, expected to be finalized in the first quarter of next year, involves AstraZeneca acquiring Icosavax for approximately $1.1 billion in cash. This acquisition values each share of Icosavax at $15, a substantial premium compared to the stock’s closing price of $10.49 on Monday.

The primary motivation behind this deal is Icosavax’s development of a potential vaccine known as IVX-A12. This vaccine aims to combat two common respiratory diseases prevalent in adults aged 60 and older: respiratory syncytial virus (RSV) and human metapneumovirus (hMPV). Presently, there are no available treatments or preventative therapies for hMPV, nor are there any combination vaccines for RSV. However, phase two trial data has shown promising results, indicating that IVX-A12 stimulates robust immune responses against both diseases.

This acquisition represents the latest development in the rapidly growing biotech and pharmaceutical industry. Notably, AbbVie made headlines with its recent announcement to acquire Cerevel Therapeutics, marking its second major deal in as many weeks. The biotech sector, in particular, has witnessed a surge in deals as the year comes to a close, creating a positive outlook for continued deal momentum into 2024.

Related posts
News

XRP Logs 4,335% Surge in Hourly Liquidation Imbalance, What's Next? - U.Today

1 Mins read
After struggling to hold steady at the $3 resistance level despite strong market momentum, XRP has finally returned to the red zone,…
News

Jurisdiction Miss Sinks Novel Crypto Suit Claim In Chancery - Law360

1 Mins read
By Jeff Montgomery ( October 6, 2025, 7:55 PM EDT) — In a first-of-its-kind decision, Delaware’s Court of Chancery on Monday upheld…
News

Japanese Stocks to Gain on Takaichi Win, Yen Drops: Markets Wrap

2 Mins read
(Bloomberg) — The yen fell after a ruling-party vote positioned pro-stimulus lawmaker Sanae Takaichi to become Japan’s next leader, boosting prospects for…

Leave a Reply

Your email address will not be published. Required fields are marked *